These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27235657)

  • 1. [Evaluation of the website of the Nord-Pas-de-Calais regional pharmacovigilance center].
    Rochoy M; Béné J; Messaadi N; Auffret M; Gautier S
    Therapie; 2016 Jun; 71(3):329-33. PubMed ID: 27235657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Satisfaction of a pharmacovigilance declaration support network in general practice].
    Driot D; Figuet L; Birebent J; Coste S; Durrieu G; Jacquot J; Bismuth M
    Therapie; 2018 Dec; 73(6):483-493. PubMed ID: 29921459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits].
    Durrieu G; Jacquot J; Baudrin D; Mège M; Rousseau V; Bagheri H; Bondon-Guitton E; Abadie D; Montastruc F; Bismuth M; Oustric S; Montastruc JL
    Therapie; 2017 Jun; 72(3):351-355. PubMed ID: 27865436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?
    Bagheri H; Lacroix I; Guitton E; Damase-Michel C; Montastruc JL
    Therapie; 2016 Apr; 71(2):235-9. PubMed ID: 27080844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of a new pharmacovigilance tool: Simplified online reporting for general practitioners].
    Humbert X; Chrétien B; Sassier M; Coquerel A; Alexandre J; Fedrizzi S
    Sante Publique; 2018; 30(2):225-232. PubMed ID: 30148310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacovigilance center --internal medicine interactions: A useful diagnostic tool].
    Rochoy M; Gautier S; Bordet R; Caron J; Launay D; Hachulla E; Hatron PY; Lambert M
    Rev Med Interne; 2015 Aug; 36(8):516-21. PubMed ID: 25771174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One step more toward pharmacovigilance 2.0. Integration of web data community for a pharmacovigilance more alert].
    Micoulaud-Franchi JA
    Presse Med; 2011 Sep; 40(9 Pt 1):790-2. PubMed ID: 21802246
    [No Abstract]   [Full Text] [Related]  

  • 8. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France.
    Auffret M; Béné J; Gautier S; Moreau-Crépeaux S; Caron J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):114-8. PubMed ID: 23810001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years].
    Picard S; Polard E; Oger E; Bellissant E
    Therapie; 2015; 70(3):293-9. PubMed ID: 25534522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacy and pharmacovigilance over a period of nine years in hospital].
    Guédat MG; Gouraud A; Ramiah T; Demazière J; Delanoy B; Vial T; Leboucher G; Charpiat B
    Therapie; 2012; 67(3):243-50. PubMed ID: 22874491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals.
    Pérez García M; Figueras A
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1295-302. PubMed ID: 21793098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feedback for patients reporting adverse drug reactions; satisfaction and expectations.
    Rolfes L; van Hunsel F; van Grootheest K; van Puijenbroek E
    Expert Opin Drug Saf; 2015 May; 14(5):625-32. PubMed ID: 25766456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.
    Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB
    Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacovigilance in Qatar: a survey of pharmacists.
    Wilbur K
    East Mediterr Health J; 2013 Nov; 19(11):930-5. PubMed ID: 24673083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected national pharmacovigilance websites: an analysis of contents.
    Barker CI; Talbot JC; Aronson JK
    Drug Saf; 2012 Feb; 35(2):141-8. PubMed ID: 22168572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is the collecting activity of regional pharmacovigilance centers influenced by regional demographic or health determinants?].
    Lam L; Desitter C; Maison P
    Therapie; 2019 Jun; 74(3):333-341. PubMed ID: 30173895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward enhanced pharmacovigilance using patient-generated data on the internet.
    White RW; Harpaz R; Shah NH; DuMouchel W; Horvitz E
    Clin Pharmacol Ther; 2014 Aug; 96(2):239-46. PubMed ID: 24713590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.